文献速递腹部MR

基于钆贝葡胺增强MRI的临床-影像特征及影像组学特征预测进展期肝纤维化

Clinic-radiological features and radiomics signatures based on Gd-BOPTA-enhanced MRI for predicting advanced liver fibrosis.
PubMed 文献 · Eur Radiol · 2022-07-19

本研究纳入102例慢性HBV感染者(训练组80例、时间独立测试组1共22例)及45例其他病因患者(测试组2),从钆贝葡胺增强MRI肝胆期提取影像组学特征构建联合模型。模型2在训练组、测试组1和测试组2的AUC分别为0.940、0.900和0.874,均高于临床-影像模型,提示影像组学特征可为临床-影像模型提供补充信息。

要点

  • 年龄(OR=1.079)和门周间隙增宽(OR=7.838)是预测进展期肝纤维化的独立因素。
  • T2WI线样或网状高信号、门周间隙增宽及肝胆期弥漫性门周强化有助于预测进展期肝纤维化。
  • 基于钆贝葡胺增强肝胆期图像的影像组学特征可为临床-影像模型提供补充信息。

核心结论

  • 基于钆贝葡胺增强肝胆期图像的影像组学特征可能为临床-影像模型提供补充信息以预测进展期肝纤维化。

研究设计与样本

  • 回顾性研究,训练组80例慢性HBV感染者,时间独立测试组1共22例,测试组2共45例其他病因患者,从钆贝葡胺增强MRI肝胆期提取影像组学特征,以多变量逻辑回归构建模型1(临床-影像因素)和模型2(模型1+影像组学特征)。

关键影像表现/征象

  • T2WI上线样或网状高信号、门周间隙增宽及肝胆期弥漫性门周强化可能有助于预测进展期肝纤维化。

诊断标准与关键数值

  • 模型2在训练组AUC为0.940,高于模型1的0.802(p=0.003);测试组1中模型2的AUC为0.900,高于模型1的0.813(p=0.131)、FibroScan的0.733(p=0.193)及血清纤维化检测APRI的0.667和Fib-4的0.791;测试组2中模型2的AUC为0.874,高于模型1的0.757(p=0.010)。

临床应用与阅片要点

  • 年龄和门周间隙增宽是预测进展期肝纤维化的独立因素,阅片时可关注T2WI线样或网状高信号、门周间隙增宽及肝胆期弥漫性门周强化等征象。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop and validate a combined model based on Gd-BOPTA-enhanced MRI to identify advanced liver fibrosis.

METHODS: A total of 102 patients with chronic HBV infection were divided into a training cohort (n = 80) and a time-independent testing cohort 1 (n = 22). In the training cohort, radiomics signatures were extracted from the hepatobiliary phase. Model 1 was constructed with clinic-radiological factors using multivariable logistic regression to predict advanced liver fibrosis, and model 2 incorporated radiomics signatures based on model 1. The diagnostic performances were compared with serum fibrosis tests and FibroScan tests using area under curve (AUC) in testing cohort 1. Another 45 patients with other causes were collected in testing cohort 2 for further validation.

RESULTS: Model 1 showed age (OR = 1.079) and periportal space widening (OR = 7.838) were the independent factors for predicting advanced fibrosis. After integrating radiomics signatures, model 2 enabled more accurately than model 1 in training cohort (0.940 vs. 0.802, p = 0.003). In testing cohort 1, model 2 demonstrated a superior AUC compared with model 1 (0.900 vs. 0.813,p = 0.131), FibroScan test (0.900 vs. 0.733, p = 0.193), and serum fibrosis tests (APRI and Fib-4 was 0.667 and 0.791). In testing cohort 2, model 2 incorporating radiomics signatures showed satisfactory performance (0.874 vs. 0.757,p = 0.010) compared with model 1.

CONCLUSIONS: Radiomics signatures derived from Gd-BOPTA-enhanced HBP images may offer complementary information to the clinic-radiological model for predicting advanced liver fibrosis.

KEY POINTS: • Linear or reticular hyperintensity on T2WI, periportal space widening, and diffuse periportal enhancement on HBP can be useful for predicting advanced liver fibrosis. • Clinic-radiological features such as patient age and periportal space widening are the two independent factors predicting advanced fibrosis. • Radiomics signatures derived from Gd-BOPTA-enhanced HBP images offer complementary information to the clinic-radiological model for predicting advanced liver fibrosis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zheng, Guo, Xiong, et al. Clinic-radiological features and radiomics signatures based on Gd-BOPTA-enhanced MRI for predicting advanced liver fibrosis. Eur Radiol. 2022. PMID: 35852575. doi:10.1007/s00330-022-08992-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。